USE OF HERBS FOR TREATMENT OF DIABETES MELLITUS
DOI:
https://doi.org/10.21272/eumj.2025;13(4);919-930Keywords:
clinical trials, diabetes mellitus, disease treatment, medicinal herbsAbstract
Introduction: Medicinal plants have been widely used in traditional medicine for their potential in managing diabetes mellitus by regulating blood sugar levels and improving overall metabolic health. As diabetes mellitus continues to be a global health problem, natural remedies derived from plants have attracted attention for their efficacy and fewer side effects compared to synthetic medicines. Many cultures traditionally rely on herbal remedies to treat diabetes-related symptoms, and modern research continues to validate these traditional practices.
Methods: The antidiabetic properties of medicinal plants are mainly attributed to their bioactive compounds, which include flavonoids, alkaloids, terpenoids, polyphenols and saponins. These substances contribute to blood sugar regulation through various mechanisms. Some plants increase insulin secretion from pancreatic beta cells, while others increase insulin sensitivity in peripheral tissues such as muscle and liver. Some medicinal plants prevent spikes in blood sugar by slowing the digestion and absorption of carbohydrates in the intestines. Moreover, some plants have antioxidant and anti-inflammatory properties, protecting pancreatic cells from damage and supporting their function.
Results: Scientific studies have shown that several medicinal plants effectively lower fasting blood glucose levels, improve glucose uptake by cells and reduce long-term glucose markers such as HbA1c. Some plants also contain soluble fibre that slows glucose absorption and improves glycaemic control. Moreover, some herbs have been shown to reduce inflammation, oxidative stress and insulin resistance, which are important factors in the progression of diabetes mellitus.
Conclusions: Although medicinal plants offer important benefits in the treatment of diabetes mellitus, their proper use, dosage and preparation methods should be carefully monitored. Possible interactions with conventional antidiabetic drugs should be taken into account and people should consult their doctor before incorporating herbal therapies into their routine.
Downloads
References
Salehi B, Ata A, Anil Kumar N, Sharopov F, Ramírez-Alarcon K, Ruiz-Ortega A, et al. Antidiabetic potential of medicinal plants and their active components. Biomolecules. 2019;30:9(10):551.
Tran N, Pham B, Le L. Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery. Biology (Basel). 2020; 28:9(9):252.
Araki A. Individualized treatment of diabetes mellitus in older adults. Geriatr Gerontol Int. 2024;24(12):1257-1268.
Sajadimajd S, Bahrami G, Daglia M, Nabavi SM, Naseri R, Farzaei MH. Plant-derived supplementary carbohydrates, polysaccharides and oligosaccharides in management of diabetes mellitus: A Comprehensive Review. Food Reviews International. 2019;35(6):563–586.
Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L. A review of its traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology. 2016;188:204–228.
Khodsooz S, Moshtaghian J, Eivani M. Antihyperglycemic and antihyperlipidemic effects of hydroalcoholic extract of melissa officinalis (lemon balm) in alloxan‐induced diabetic rats. Physiology and Pharmacology. 2016;20(1):24–30.
Javid AZ, Haybar H, Dehghan P, Haghighizadeh MH, Mohaghegh SM, Ravanbakhsh M. The effects of melissa officinalis (lemon balm) in chronic stable angina on serum biomarkers of oxidative stress, inflammation and lipid profile. Asia Pac J Clin Nutr. 2018;27(4):785-791. https://doi.org/10.6133/apjcn.022018.01.
Jandaghi P, Noroozi M, Ardalani H, Alipour M. Lemon balm: A promising herbal therapy for patients with borderline hyperlipidemia— A randomized double‐blind placebo‐controlled clinical trial. Complementary Therapies in Medicine. 2016;26:136–140.
Asadi A, Shidfar F, Safari M, Hosseini AF, Fallah Huseini H, Heidari I, et al. Efficacy of Melissa officinalis L. (lemon balm) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: A randomized, double-blind, clinical trial. Phytother Res. 2019;33(3):651-659. https://doi.org/10.1002/ptr.6254.
Sirajudheen A, Sandhya D, Maryam E, Akram E. Antidiabetic Activities of Fenugreek (Trigonella foenum-graecum) Seeds. Nuts and Seeds in Health and Disease Prevention. 2011;469–478.
Sarker DK, Ray P, Dutta AK, Rouf R, Uddin SJ. Antidiabetic potential of fenugreek (Trigonella foenum-graecum): A magic herb for diabetes mellitus. Food Sci Nutr. 2024;12(10):7108-7136. https://doi.org/10.1002/fsn3.4440.
Fattahi A, Niyazi F, Shahbazi B, Farzaei MH, Bahrami G. Antidiabetic Mechanisms of Rosa canina Fruits: An In Vitro Evaluation. J Evid Based Complementary Altern Med. 2017;22(1):127-133. https://doi.org/10.1177/2156587216655263.
Saatchi A, Aghamohammadzadeh N, Beheshtirouy S, Javadzadeh Y, Afshar FH, Ghaffary S. Anti-hyperglycemic effect of Abelmoschus culentesus (Okra) on patients with diabetes type 2: a randomized clinical trial. Phytother Res. 2022;36(4):1644-1651. https://doi.org/10.1002/ptr.7341.
Tavakolizadeh M, Peyrovi S, Ghasemi-Moghaddam H, Bahadori A, Mohkami Z, Sotoudeh M, et al. Clinical efficacy and safety of okra (Abelmoschus esculentus (L.) Moench) in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. Acta Diabetol.2023;60(12):1685-1695. https://doi.org/10.1007/s00592-023-02149-1.
Safari M, Asadi A, Aryaeian N, Huseini HF, Shidfar F, Jazayeri S, et al. The effects of melissa officinalis on depression and anxiety in type 2 diabetes patients with depression: a randomized double-blinded placebo-controlled clinical trial. BMC Complement Med Ther. 2023;23(1):140. https://doi.org/10.1186/s12906-023-03978-x.
Geberemeskel GA, Debebe YG, Nguse NA. Antidiabetic Effect of Fenugreek Seed Powder Solution (Trigonella foenum-graecum L.) on Hyperlipidemia in Diabetic Patients. J Diabetes Res. 2019;2019:8507453. https://doi.org/10.1155/2019/8507453.
Majnooni MB, Ataee M, Bahrami G, Heydarpour F, Aneva IY, Farzaei MH, et al. The effects of co-administration of artichoke leaf extract supplementation with metformin and vitamin E in patients with nonalcoholic fatty liver disease: A randomized clinical trial. Phytother Res. 2021;35(11):6324-6334. https://doi.org/10.1002/ptr.7279.
Mehrzadi S, Mirzaei R, Heydari M, Sasani M, Yaqoobvand B, Huseini HF. Efficacy and Safety of a Traditional Herbal Combination in Patients with Type II Diabetes Mellitus: A Randomized Controlled Trial. J Diet Suppl. 2021;18(1):31-43. https://doi.org/10.1080/19390211.2020.1727076.
Abolghasemi J, Farboodniay Jahromi MA, Hossein Sharifi M, Mazloom Z, Hosseini L, Zamani N, et al. Effects of Zataria oxymel on obesity, insulin resistance and lipid profile: A randomized, controlled, triple-blind trial. J Integr Med. 2020;8(5):401-408. https://doi.org/10.1016/j.joim.2020.06.003.
Wasana KGP, Attanayake AP, Weerarathna TP, Jayatilaka KAPW. Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A double blind randomized placebo controlled clinical trial. Phytomedicine. 2021;81:153431. https://doi.org/10.1016/j.phymed.2020.153431.
Gupta RS, Grover AS, Kumar P, Goel A, Banik SP, Chakraborty S, et al. A randomized double blind placebo controlled trial to assess the safety and efficacy of a patented fenugreek (Trigonella foenum-graecum) seed extract in Type 2 diabetics. Food Nutr Res. 2024;3;68. https://doi.org/10.29219/fnr.v68.10667.
Assaad-Khalil S, Elkafrawy N, Khaled M, Mogeib O, Badr H, Rashwan A, et al. A Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus. Evid Based Complement Alternat Med. 2022;2022:1-11. https://doi.org/10.1155/2022/9176026.
Mehri D, Abdorreza Mohammadi N, Leila N, Ahmad K, Aisa B, Hossein E. The Effect of Bread Enriched With Portulaca Oleracea on Metabolic Control Indices in Patients With Type 2 Diabetes: a Parallel Randomized Clinical Trial. Research square, 2021;1-16. https://doi.org/10.21203/rs.3.rs-215837/v1.
Khaled MA, Ahmed AA, Abdulfatah MNA and Ammar MA. A Comparative study between Male and Female with Type 2 Diabetic based on the effect of cinnamon supplementation on fasting serum glucose, triglyceride, total cholesterol levels, and blood pressure, Al-Baydha University Journal. 2020; 2(3):112-122.
Mohamed FD, Amany IA and Hanaa RM. Antidiabetic Effect of Pumpkin Seeds and Gum Arabic and/or Vildagliptin on type 2 Induced Diabetes in Male Rats. International Journal of Veterinary Science. 2020;9(2):229-233.
Dhuha WS, Husamuldeen SA, Dakheel HH, Buthina AA, Muthanna S. Ameliorative Effects of Adansonia digitata on Diabetes in Albino Rats. Enhanced Biochemical Responses. 2024;7(2);25-35.
Yosef EA, Kassahun D, Tsegahun A. Antidiabetic Activity of Mung Bean or Vigna radiata (L.) Wilczek Seeds in Alloxan-Induced Diabetic Mice. Evidence-Based Complementary and Alternative Medicine. 2022;1(2022):1-12
Tofighi Z, Moradi-Afrapoli F, Ebrahimi SN, Goodarzi S, Hadjiakhoondi A, Neuburger M. at al. Securigenin glycosides as hypoglycemic principles of Securigera securidaca seeds. J Nat Med. 2017;71(1):272-280. https://doi.org/10.1007/s11418-016-1060-7.
Azadbakht M, Ahmadi S A, Ahangar N. Antidiabetic Activity of Aqueous Seed Extract of Securigera securidaca in Streptozotocin Induced Diabetic Rats. J Adv Med Biomed Res. 2019;27 (123):16-22.
Porchezhian E, Ansari SH. Effect of Securigera securidaca on Blood Glucose Levels of Normal and Alloxan-Induced Diabetic Rats. Pharmaceutical Biology. 2008;39(1):62-64.
Seyed SR, Behrouz T, Zahra G. The effects of silymarin on type 2 diabetes mellitus: A systematic review and meta-analysis. Obesity Medicine. 2021;26:100368
Mai SM, Malik H, Shtaywy A. Hypolipidemic and Hypoglycemic Effects of Silybum marianum (L.) Gaertn. (Milk Thistle) Ethanol Seed Extract in Streptozotocin-induced Diabetes in Rats. Pharmacognosy Magazine. 2024;20(3):841-852. https://doi.org/10.1177/09731296241231104
Hou D, Yousaf L, Xue Y, Hu J, Wu J, Hu X at al. Mung Bean (Vigna radiata L.): Bioactive Polyphenols, Polysaccharides, Peptides, and Health Benefits. Nutrients. 2019;11(6):1238. https://doi.org/10.3390/nu11061238.
Chandrasekharan C, Bhat S. Potential effects of Mudga (Vigna radiata L. Wilczek) as a dietetic food and medication for diabetes. Journal of Ayurveda and Integrated Medical Sciences. 2024;8(12): 230-235.
Maideen NMP. Antidiabetic Activity of Nigella Sativa (Black Seeds) and Its Active Constituent (Thymoquinone): A Review of Human and Experimental Animal Studies. Chonnam Med J. 2021;57(3):169-175. https://doi.org/10.4068/cmj.2021.57.3.169.
Adam SH, Mohd Nasri N, Kashim MIAM, Abd Latib EH, Ahmad Juhari MAA, Mokhtar MH. Potential health benefits of Nigella sativa on diabetes mellitus and its complications: A review from laboratory studies to clinical trials. Front Nutr. 2022;10;9:1057825. https://doi.org/10.3389/fnut.2022.1057825.
Bai Y, Zang X, Ma J, Xu G. Anti-Diabetic Effect of Portulaca oleracea L. Polysaccharideandits Mechanism in Diabetic Rats. Int J Mol Sci. 2016;17(8):1201. https://doi.org/10.3390/ijms17081201.
Jalali J, Ghasemzadeh Rahbardar M. Ameliorative effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: A review. J Ethnopharmacol. 2022;299:115672. https://doi.org/10.1016/j.jep.2022.115672.
Made WAP, Nanang F, Arief N, Subagus W. Antidiabetic activity of Coccinia grandis (L.) Voigt: Bioactive constituents, mechanisms of action, and synergistic effects. Journal of Applied Pharmaceutical Science. 2022;12(01):041-054.
Putra IMWA, Fakhrudin N, Nurrochmad A, Wahyuono S. Antidiabetic effect of combined extract of Coccinia grandis and Blumea balsamifera on streptozotocin-nicotinamide induced diabetic rats. J Ayurveda Integr Med. 2024;15(4):101021. https://doi.org/10.1016/j.jaim.2024.101021.
Aminizadeh M, Kavoosi G, Kariminia A. In vitro and ex vivo anti-diabetic and anti-hyperglycemic properties of Zataria multiflora essential oil. Mol Biol Rep. 2020;47(10):7805-7813. https://doi.org/10.1007/s11033-020-05857-x.
Vahid H, Rakhshandeh H, Ghorbani A. Antidiabetic properties of Capparis spinosa L. and its components. Biomed Pharmacother. 2017;92:293-302. https://doi.org/10.1016/j.biopha.2017.05.082.
Eddouks M, Lemhadri A, Hebi M, El Hidani A, Zeggwagh NA, El Bouhali B, et al. Capparis spinosa L. aqueous extract evokes antidiabetic effect in streptozotocin-induced diabetic mice. Avicenna J Phytomed. 2017;7(2):191-198.
Asgary S, Soltani R, Mirvakili S, Sarrafzadegan N. Evaluation of the effect of Vaccinium arctostaphylos L. fruit extract on serum inflammatory biomarkers in adult hyperlipidemic patients: a randomized double-blind placebo-controlled clinical trial. Res Pharm Sci. 2016;11(4):343-8. https://doi.org/10.4103/1735-5362.189321.
Shahrokhi M, Koohmanaee S, Haghghi R, Hassanzadeh Rad A, Esfandiari MA, Shirin P, et al. Urtica dioica (Nettle) in Type 1 Diabetes Mellitus: A Randomized Controlled Trial. Iran J Pediatr. 2023;33(5):e137563.
Altamimi MA, Abu-Reidah IM, Altamimi A, Jaradat N. Hydroethanolic Extract of Urtica dioica L. (Stinging Nettle) Leaves as Disaccharidase Inhibitor and Glucose Transport in Caco-2 Hinderer. Molecules. 2022;27(24):8872. https://doi.org/10.3390/molecules27248872.
Rehman G, Khan I, Rauf A, Rashid U, Siddique A, Shah SMM, et al. Antidiabetic Properties of Caffeoylmalic Acid, a Bioactive Natural Compound Isolated from Urtica dioica. Fitoterapia. 2024;176:106024. https://doi.org/10.1016/j.fitote.2024.106024.
Sabitha V, Ramachandran S, Naveen KR, Panneerselvam K. Antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus (L.) Moench. in streptozotocin-induced diabetic rats. J Pharm Bioallied Sci. 2011;3(3):397-402. https://doi.org/10.4103/0975-7406.84447.
Muhammad HS, Asma A, Sumreen H, Bilal A, Fakhar-e-Alam M, Saima M et al. Antidiabetic and antioxidant potentials of Abelmoschus esculentus: In vitro combined with molecular docking approach, Journal of Saudi Chemical Society, 2022;26(2):101418.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mahruh Mahmud Nagiyeva, Aytakin Sabuhi Mammadova, Aybaniz Turkan Tagizade, Oktay Veli Aliyev, Huseyn Ceyhun Kazimzade
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN: 
